1. Home
  2. NKSH vs MDWD Comparison

NKSH vs MDWD Comparison

Compare NKSH & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKSH
  • MDWD
  • Stock Information
  • Founded
  • NKSH 1891
  • MDWD 2000
  • Country
  • NKSH United States
  • MDWD Israel
  • Employees
  • NKSH N/A
  • MDWD N/A
  • Industry
  • NKSH Major Banks
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • NKSH Finance
  • MDWD Health Care
  • Exchange
  • NKSH Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • NKSH 185.2M
  • MDWD 195.2M
  • IPO Year
  • NKSH N/A
  • MDWD 2014
  • Fundamental
  • Price
  • NKSH $29.05
  • MDWD $18.44
  • Analyst Decision
  • NKSH Strong Buy
  • MDWD Strong Buy
  • Analyst Count
  • NKSH 1
  • MDWD 2
  • Target Price
  • NKSH $38.00
  • MDWD $35.00
  • AVG Volume (30 Days)
  • NKSH 5.5K
  • MDWD 82.0K
  • Earning Date
  • NKSH 10-23-2025
  • MDWD 11-25-2025
  • Dividend Yield
  • NKSH 5.18%
  • MDWD N/A
  • EPS Growth
  • NKSH 41.83
  • MDWD N/A
  • EPS
  • NKSH 2.04
  • MDWD N/A
  • Revenue
  • NKSH $51,980,000.00
  • MDWD $19,858,000.00
  • Revenue This Year
  • NKSH $2.95
  • MDWD $21.39
  • Revenue Next Year
  • NKSH $9.97
  • MDWD $23.01
  • P/E Ratio
  • NKSH $14.27
  • MDWD N/A
  • Revenue Growth
  • NKSH 19.64
  • MDWD N/A
  • 52 Week Low
  • NKSH $23.75
  • MDWD $14.14
  • 52 Week High
  • NKSH $32.89
  • MDWD $22.51
  • Technical
  • Relative Strength Index (RSI)
  • NKSH 47.38
  • MDWD 52.89
  • Support Level
  • NKSH $28.03
  • MDWD $18.11
  • Resistance Level
  • NKSH $29.48
  • MDWD $20.03
  • Average True Range (ATR)
  • NKSH 0.61
  • MDWD 0.71
  • MACD
  • NKSH 0.02
  • MDWD 0.01
  • Stochastic Oscillator
  • NKSH 49.50
  • MDWD 45.72

About NKSH National Bankshares Inc.

National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: